This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Philips Drives Discussion At American Telemedicine Association Conference

Stocks in this article: PHG

ANDOVER, Mass., May 16, 2014 /PRNewswire/ --  Royal Philips (NYSE: PHG AEX: PHIA) today announced its participation in the American Telemedicine Association's 2014 Conference (ATA 14) to be held May 18-20 in Baltimore, Md. At this year's event, Philips experts and healthcare professionals and administrators will highlight best practices for telehealth to increase efficiencies, add value, improve care and achieve higher standards across the entire care continuum from the hospital into the home.

"The use of telehealth will increase as health systems continue to explore more efficient, cost-effective and collaborative ways of treating patients both in and out of the hospital," said Derek Smith, chief executive officer, Hospital to Home, Philips Healthcare. "Our focus at this year's ATA is to highlight a new kind of leadership, delivering a programmatic, insight-driven and patient-centric approach to telehealth, as well as the supporting technologies that enable clinical transformation across all care settings."

The Philips Hospital to Home booth (#4610) will also spotlight its full suite of telehealth programs, including acute, critical and ambulatory care programs.

Conference Agenda Features Hospital to Home Healthcare professionals and hospital administrators lead discussions on maximizing telehealth investments and achieving results at several sessions, including:

  • Industry Council Executive Session
    • Manu Varma, vice president of strategy and business development at Philips Hospital to Home
    • Monday, May 19, 3:00-4:00 PM, Room 307/308

Philips Telehealth Solutions in Action  The centerpiece of the Philips Hospital to Home booth will be an enterprise-wide telehealth center, where visitors can see how remote monitoring connected solutions enhance the care of patients in high acuity settings in the hospital and lower acuity settings in the home, through six different clinical programs. Philips will feature its newest program, eAcute, which supports proactive patient population management in medical and surgical units.

In addition, the Philips eICU technology will be featured by Mercy (booth #2414). Mercy is currently managing more than 450 intensive care unit beds as part of a broad, innovative telehealth program that also extends care to medical/surgical units as well as outpatient and home settings.

For more information on Philips' presence at ATA 14, including the full suite of Philips clinical telehealth programs, visit www.hospitaltohome.philips.com and follow the #ATA2014 conversation @PhilipsHealth

About Royal Philips: Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 112,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter .

SOURCE Royal Philips

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,678.70 +6.10 0.03%
S&P 500 2,057.09 +5.27 0.26%
NASDAQ 4,771.7630 +13.8840 0.29%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs